The goal of this study was to determine if there is a basal release of nitric oxide that affects long-term arterial pressure regulation in dogs. Studies were conducted over a 23-day period in eight conscious dogs with indwelling catheters. Nitric oxide synthesis was blocked by continuous intravenous infusion of nitro-L-arginine-methyl ester at 37.1 nmol/kg per minute for 11 days. Arterial pressure increased to 120±4% of control on the first day, decreased for a few days, and then increased to a maximum value of 122±6% of control on day 7. Bradycardia was sustained throughout the entire nitro-arginine period. Blockade of nitric oxide synthesis was evidenced by attenuated pressure and flow responses to systemic acetylcholine infusion. The pressor response to phenylephrine was increased for only 1 day, and the hypotensive effects of nitroprusside were enhanced. Also, the variability of arterial pressure was significantly increased during nitro-arginine. Sodium and water balances were positive the first day of nitro-arginine infusion but were unchanged for the entire nitro-arginine period. In conclusion, the data suggest that blockade of the basal release of nitric oxide in dogs causes an increase in the long-term level of arterial pressure without any sustained sodium or water retention. (Hypertension 1993;22:40-48) KEY WORDS • endothelium • vasodilation • arginine • nitric oxide • hypertension, essential I n 1980 Furchgott and Zawadzki 1 found that acetyl-choline-induced relaxation of vascular strips or rings was dependent on the presence of an intact endothelium. A substance released from the endothe-lium, later known as endothelium-derived relaxing factor (EDRF), was primarily responsible for this relaxation. Furchgott 2 later suggested that EDRF was nitric oxide (NO), and Ignarro et al 3 speculated that EDRF might be NO or a related compound. Other investigators have confirmed that NO is an integral part of EDRF, and specific NO synthesis inhibitors have been successfully developed. 4 The two major inhibitors of NO production are JV G-monomethyl L-arginine (L-NMMA) and Af G-nitro-L-arginine-methyl ester (L-NAME), and they both act by competitive inhibition of NO synthase. This inhibition prevents the conversion of L-arginine to NO. Of these two inhibitors, L-NAME is much more potent and causes acute vasoconstriction in a number of vascular beds, whereas D-NAME does not. 5 Most experiments on NO synthesis blockade have been performed in vitro on vascular rings. However, more recently, administration of NO synthesis blockers resulted in acute increases in arterial pressure in rats, 6 ' 7 guinea pigs, 8 and rabbits. 9 In addition, studies by Gar-diner et al 5 and Baylis et al 10 showed that administration of L-NAME for several hours to conscious rats resulted in increases in arterial pressure. More recently, several longer experiments have been performed in which NOson, MS 39216-4505 (Dr Manning). synthesis inhibitors were administered to rats orally for periods lasting between 9 hours and 6 months, and mean arter...